ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...
“These findings show that being familiar with a device doesn’t necessarily mean people feel confident using it in real life – or comfortable carrying it day to day,” said Sarah Lacquiere, co-author ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results